Sanlam Morocco has acquired a minority, non-controlling stake in Dislog Group. This investment, totaling 150 million dirhams, will enable Dislog Group to strengthen its healthcare division and drive further development through external growth (M&A) in the pharmaceutical and medical device sectors. Dislog Group owns several specialized entities, including Megaflex, Kosmopharm, Steripharma, Somapharma, Africare, and Dislog Santé. Its healthcare division is structured around three business units: the pharmaceutical industry, medical devices, and dermo-cosmetics, offering a complete value chain from drug manufacturing to the distribution of specialized equipment. This investment aligns with an expansion strategy in a rapidly growing sector in Morocco, further consolidating Dislog Group's position in the healthcare market. On this occasion, Yahia Chraibi, General Manager of Sanlam Morocco, stated: «Sanlam and Dislog share a common commitment to innovation and service excellence. By investing in such a dynamic Moroccan player, we reaffirm our commitment to supporting the national economy, particularly in the healthcare sector, where we have recognized expertise.» «Sanlam's entry into our capital further institutionalizes our ownership. As a Moroccan leader in FMCG and healthcare, we are eager to accelerate our international development, a vision we share with Sanlam», Moncef Belkhayat, Chairman and CEO of Dislog Group, added.
